相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2021)
Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells
Michele J. Hoffmann et al.
GENES (2021)
Trimethylacetic Anhydride-Based Derivatization Facilitates Quantification of Histone Marks at the MS1 Level
Hana Kucharikova et al.
MOLECULAR & CELLULAR PROTEOMICS (2021)
Mitochondrial TCA cycle metabolites control physiology and disease
Inmaculada Martinez-Reyes et al.
NATURE COMMUNICATIONS (2020)
The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1
Oleg Kruglov et al.
BLOOD ADVANCES (2020)
Mechanism of Action for HDAC Inhibitors-Insights from Omics Approaches
Wenbo Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death
Maria Mrakovcic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Different Modes of Action of Genetic and Chemical Downregulation of Histone Deacetylases with Respect to Plant Development and Histone Modifications
Gabriela Lochmanova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Functions and mechanisms of non-histone protein acetylation
Takeo Narita et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Acetylation of 53BP1 dictates the DNA double strand break repair pathway
Xiang Guo et al.
NUCLEIC ACIDS RESEARCH (2018)
Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells
Benigno C. Valdez et al.
ONCOTARGET (2018)
HDAC inhibitor PAC-320 induces G2/M cell cycle arrest and apoptosis in human prostate cancer
Zhixiong Dong et al.
ONCOTARGET (2018)
Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond
Nina Prokoph et al.
CANCERS (2018)
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera et al.
FRONTIERS IN ONCOLOGY (2018)
From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK plus ALCL)
Michael T. Werner et al.
CANCERS (2017)
HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation
Dhanusha A. Nalawansha et al.
CELL CHEMICAL BIOLOGY (2017)
Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin
Carine Robert et al.
LEUKEMIA RESEARCH (2016)
Targeting the cancer epigenome for therapy
Peter A. Jones et al.
NATURE REVIEWS GENETICS (2016)
The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair
Wynand Paul Roos et al.
NUCLEIC ACIDS RESEARCH (2016)
Class I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy
Kristy R. Stengel et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
HDAC inhibitors still need a home run, despite recent approval
Malini Guha
NATURE REVIEWS DRUG DISCOVERY (2015)
50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond
Eric Verdin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes
Isabelle Becher et al.
ACS CHEMICAL BIOLOGY (2014)
Keeping 53BP1 out of focus in mitosis
Rimma Belotserkovskaya et al.
CELL RESEARCH (2014)
Nonenzymatic Protein Acylation as a Carbon Stress Regulated by Sirtuin Deacylases
Gregory R. Wagner et al.
MOLECULAR CELL (2014)
Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
Victoria L. Luchenko et al.
MOLECULAR ONCOLOGY (2014)
Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae
Brian T. Weinert et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
CD4+ T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2
Nicole Boucheron et al.
NATURE IMMUNOLOGY (2014)
The growing landscape of lysine acetylation links metabolism and cell signalling
Chunaram Choudhary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
HDAC1 Controls CD8+ T Cell Homeostasis and Antiviral Response
Roland Tschismarov et al.
PLOS ONE (2014)
The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts
Richard D. W. Kelly et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function
Marinus R. Heideman et al.
BLOOD (2013)
Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice
Oliver M. Dovey et al.
BLOOD (2013)
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
Fabio Santoro et al.
BLOOD (2013)
Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
Mircea Winter et al.
EMBO JOURNAL (2013)
Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
Benjamin E. L. Lauffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation
Fade Gong et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2013)
Histone deacetylase complexes as caretakers of genome stability
Robert S. Lahue et al.
EPIGENETICS (2012)
A combined approach for the study of histone deacetylase inhibitors
Lenka Cincarova et al.
MOLECULAR BIOSYSTEMS (2012)
The functions and regulation of the PTEN tumour suppressor
Min Sup Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
Teppei Yamaguchi et al.
GENES & DEVELOPMENT (2010)
Conditional Deletion of Histone Deacetylase 1 in T Cells Leads to Enhanced Airway Inflammation and Increased Th2 Cytokine Production
Reinhard Grausenburger et al.
JOURNAL OF IMMUNOLOGY (2010)
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
J-H. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Isoform-specific histone deacetylase inhibitors: The next step?
Sriram Balasubramanian et al.
CANCER LETTERS (2009)
Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes
Zhibin Wang et al.
CELL (2009)
DNA damage foci in mitosis are devoid of 53BP1
Glyn Nelson et al.
CELL CYCLE (2009)
The Direct Interaction between 53BP1 and MDC1 Is Required for the Recruitment of 53BP1 to Sites of Damage
Yifat Eliezer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glucose Metabolism as a Target of Histone Deacetylase Inhibitors
Suzanne E. Wardell et al.
MOLECULAR ENDOCRINOLOGY (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
PTEN acetylation modulates its interaction with PDZ domain
Tsuneo Ikenoue et al.
CANCER RESEARCH (2008)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
A functional link between SIRT1 deacetylase and NBS1 in DNA damage response
Zhigang Yuan et al.
CELL CYCLE (2007)
Pathobiology of ALK+ anaplastic large-cell lymphoma
Hesham M. Amin et al.
BLOOD (2007)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms
Suzanne D. Turner et al.
CELLULAR SIGNALLING (2007)
Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Francisco Vega et al.
CANCER RESEARCH (2006)
Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription
F Faiola et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM
YL Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Stat3 dimerization regulated by reversible acetylation of a single lysine residue
ZL Yuan et al.
SCIENCE (2005)
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
R Chiarle et al.
BLOOD (2003)
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
RW Johnstone
NATURE REVIEWS DRUG DISCOVERY (2002)
分享论文
